Focus Partners Wealth

Position in VTRS — Viatris Inc

CIK 1542153 ST LOUIS, MO

Position in VTRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,783,779

+$96,780 QoQ

Shares Held

132,034

-2.6% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 43.53717635774057.ToString("F0")% Shared 0.ToString("F0")% None 56.46282364225943.ToString("F0")%

Healthcare · as of Mar 31, 2026

Focus Partners Wealth holds $54,434,760 across 17 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	137,784	$16,287,446
2	NBIX	Neurocrine Biosciences Inc	80,335	$10,583,332
3	TAK	Takeda Pharmaceutical Co Ltd	482,387	$8,933,807
4	LNTH	Lantheus Holdings, Inc.	72,517	$5,500,414
5	UTHR	UNITED THERAPEUTICS Corp	5,854	$3,471,304
6	ALKS	Alkermes plc.	77,052	$2,724,558
7	HLN	Haleon plc	195,548	$1,957,435
8	VTRS	Viatris Inc This page	132,034	$1,783,779

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,783,779	132,034	-2.6%	Shares	Sole	2026-05-15
2025-12-31	$1,686,999	135,502	+124.7%	Shares	Sole	2026-02-13
2025-09-30	$597,088	60,312	-81.4%	Shares	Sole	2025-11-14
2025-06-30	$2,894,123	324,090	+2.9%	Shares	Sole	2025-08-14
2025-03-31	$2,742,996	314,925	-12.3%	Shares	Sole	2025-05-20
2024-12-31	$4,471,467	359,154	+71.9%	Shares	Sole	2025-05-29
2024-09-30	$2,426,339	208,987	-48.2%	Shares	Sole	2024-11-14
2024-06-30	$4,291,564	403,722	+114.9%	Shares	Sole	2024-08-15
2024-03-31	$2,242,618	187,824	+1414.1%	Shares	Sole	2024-05-16
2023-12-31	$134,346	12,405	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.